19 results
DEF 14A
TSBX
Turnstone Biologics Corp
22 Apr 24
Definitive proxy
4:28pm
represent the long-term interests of the Company’s stockholders. However, the Nominating and Corporate Governance Committee retains the right to modify … of Directors, the operating requirements of the Company and the long-term interests of stockholders. In conducting this assessment, the Nominating
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
difficult to treat. Despite advances in the oncology treatment landscape, solid tumors continue to result in low rates of long-term survival in the United … of patients in the intended therapeutic indication, particularly for long-term safety follow-up. During all phases of clinical development, regulatory
8-K
EX-99.1
TSBX
Turnstone Biologics Corp
5 Mar 24
Regulation FD Disclosure
8:30am
1.6M 500K 90%+ new cancer patients1 deaths with low long-term survival1 mortality in metastatic disease2 In the U.S. Each Year New Therapeutic Options
10-Q
uw1w50x3 i1f97d6mr
1 Sep 23
Quarterly report
4:39pm
424B4
aio9vyq0e9o8n
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
iztnaj
23 Jun 23
IPO registration (amended)
9:49pm
S-1
EX-10.10
k32qldsbg6sl fdit
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.9
xhf81eeagnmy0v6vj
12 Jun 23
IPO registration
4:28pm
S-1
v42 ucjjevgw
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.1
l8spk d5tu
12 Jun 23
IPO registration
4:28pm
S-1
EX-2.1
vdu96ya
12 Jun 23
IPO registration
4:28pm
DRS
EX-2.1
fu73 6sey0f
15 May 23
Draft registration statement
12:00am
DRS
EX-10.10
y24v5ojng7
15 May 23
Draft registration statement
12:00am
DRS
EX-10.9
0npeepfw2 yxc6k0in6
15 May 23
Draft registration statement
12:00am
DRS
6pnc9u
15 May 23
Draft registration statement
12:00am
DRS
EX-10.1
acqzs10g1yrjd yeoysd
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next